Health Problem: Diabetes is a chronic, progressive disease characterized by impaired metabolism of carbohydrates. Diabetes affects approximately 30 million Americans (9.4% of the population) and costs $327 billion annually in the United States.
Technology Description: The V-Go Insulin Delivery Device is a mechanical, self-contained, single-use disposable insulin infusion device that adheres to the skin.
Controversy: Injections that administer insulin in intermittent boluses are indiscreet and inconvenient and may cause pain. Electronic pumps provide continuous infusion of insulin, which is a more natural state; however, the devices are cumbersome and costly. The V-Go Disposable Insulin Delivery Device represents a small, discreet, and less costly alternative to traditional insulin pumps. It is unknown whether administering insulin with the V-Go device has a greater impact on sustained glycemic control than administration of insulin via multiple daily injections.
- Is the V-Go Disposable Insulin Delivery Device effective in controlling blood glucose levels in adults with diabetes?
- How does the V-Go device compare with multiple daily injections of insulin or other insulin infusion devices?
- Is the V-Go device safe?
- Have definitive patient selection criteria been identified for the V-Go device?
If you have a Hayes login, click here to view the full report on the Knowledge Center.